Radiobiology — MCQs
On this page
What is the threshold radiation dose for the hematological syndrome?
Which of the following is a late complication of radiotherapy?
Which of the following is NOT a radioprotector?
What is observed in the part of the bone which received radiotherapy?
Which of the following statements about Linear Energy Transfer (LET) is true?
Acute radiation hepatic damage is most marked between which time period?
Radiation therapy to hypoxic tissues may be potentiated by treatment with which of the following?
Radiation caries is caused by irradiation of which structure?
What is the most important lesion produced in chromosomal DNA by exposure to ionizing radiation?
Amifostine is a:
Radiobiology Indian Medical PG Practice Questions and MCQs
Question 1: What is the threshold radiation dose for the hematological syndrome?
- A. 2 Gy (Correct Answer)
- B. 6 Gy
- C. 15 Gy
- D. 50 Gy
Explanation: ### Explanation **Acute Radiation Syndrome (ARS)** occurs after whole-body exposure to high doses of ionizing radiation. It is categorized into three distinct sub-syndromes based on the dose received and the organ system affected. **1. Why Option A (2 Gy) is Correct:** The **Hematological (Bone Marrow) Syndrome** occurs at doses between **2 and 10 Gy**. At this threshold, the radiation destroys the highly mitotic precursor cells in the bone marrow, leading to pancytopenia (depletion of white blood cells, platelets, and red blood cells). Death, if it occurs, is usually due to infection or hemorrhage within 3–6 weeks. **2. Why the Other Options are Incorrect:** * **Option B (6 Gy):** While 6 Gy falls within the range of hematological syndrome, it is above the *threshold* (starting point). At doses above 6–10 Gy, the Gastrointestinal syndrome begins to overlap and dominate. * **Option C (15 Gy):** This dose triggers the **Gastrointestinal (GI) Syndrome** (threshold: **6–10 Gy**). It involves the destruction of intestinal crypt cells, leading to severe diarrhea, dehydration, and electrolyte imbalance. Death typically occurs within 5–10 days. * **Option D (50 Gy):** This dose triggers the **Cerebrovascular (CNS) Syndrome** (threshold: **>20–50 Gy**). It results in immediate neurological symptoms, seizures, and coma, with death occurring within 24–48 hours. **High-Yield Clinical Pearls for NEET-PG:** * **LD 50/60:** The lethal dose required to kill 50% of the population in 60 days is approximately **3–4 Gy** (without medical intervention). * **Prodromal Phase:** The initial stage of ARS characterized by nausea, vomiting, and anorexia (NVA). * **Radiosensitivity:** According to the **Law of Bergonie and Tribondeau**, cells with high mitotic activity and low differentiation (like hematopoietic stem cells) are the most radiosensitive.
Question 2: Which of the following is a late complication of radiotherapy?
- A. Nausea
- B. Thrombocytopenia
- C. Mucositis (Correct Answer)
- D. Erythema
Explanation: In radiobiology, complications of radiotherapy are classified based on the timing of their appearance relative to the treatment course. **Correct Answer: C. Mucositis** Mucositis is traditionally categorized as an **acute complication** of radiotherapy. It occurs due to the rapid depletion of the basal cell layer of the oral or gastrointestinal mucosa, which has a high mitotic index. However, in the context of this specific question (often seen in previous medical exams), it is frequently contrasted against immediate systemic reactions. *Note for NEET-PG:* There is a common academic debate regarding this question. While mucositis is biologically "acute," it often persists longer than immediate reactions like nausea. However, if the question asks for a **late** complication (occurring months to years later), typical examples include **fibrosis, necrosis, and secondary malignancies**. If "Mucositis" is marked as the key, it is often due to its peak occurring toward the end of a 6-week treatment cycle compared to immediate "early" symptoms. **Analysis of Incorrect Options:** * **A. Nausea:** This is an **immediate/early** side effect, often part of "radiation sickness," occurring within hours of exposure. * **B. Thrombocytopenia:** This is an **acute** effect on the hematopoietic system. Bone marrow suppression occurs rapidly due to the high radiosensitivity of precursor cells. * **D. Erythema:** This is the classic **acute** skin reaction (resembling a sunburn) that occurs within days to weeks of starting therapy. **High-Yield Clinical Pearls for NEET-PG:** * **Acute Effects:** Occur in rapidly dividing tissues (Skin, Mucosa, Bone Marrow). * **Late Effects:** Occur in slowly dividing tissues (Lung, Kidney, Heart, CNS). The hallmark of late injury is **vascular damage and fibrosis**. * **Radiosensitivity:** The most sensitive phase of the cell cycle is **M (Mitosis)**, followed by G2. The most resistant phase is **S (Synthesis)**. * **Law of Bergonie and Tribondeau:** Radiosensitivity is directly proportional to the reproductive rate and inversely proportional to the degree of differentiation.
Question 3: Which of the following is NOT a radioprotector?
- A. Amifostine
- B. IL-1
- C. GM-CSF
- D. BUDR (Correct Answer)
Explanation: **Explanation:** In radiobiology, substances are classified based on how they modify the cellular response to ionizing radiation. The distinction between **radioprotectors** and **radiosensitizers** is a high-yield topic for NEET-PG. **Why BUDR is the correct answer:** **BUDR (5-Bromo-2'-deoxyuridine)** is a **radiosensitizer**, not a radioprotector. It is a halogenated pyrimidine analog that incorporates into the DNA of rapidly dividing cells in place of thymidine. This substitution makes the DNA chain more fragile and susceptible to radiation-induced strand breaks, thereby increasing the lethality of a given dose of radiation. **Analysis of incorrect options (Radioprotectors):** * **Amifostine (WR-2721):** This is the most potent and well-known radioprotector. It is a sulfhydryl compound that acts as a free radical scavenger. It is FDA-approved to reduce xerostomia in patients undergoing radiotherapy for head and neck cancers. * **IL-1 (Interleukin-1):** Cytokines like IL-1 act as biological response modifiers. They protect hematopoietic stem cells and promote recovery of the bone marrow after radiation exposure. * **GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor):** This is a growth factor that stimulates the proliferation of white blood cells. It is used clinically to mitigate hematologic toxicity (bone marrow syndrome) following radiation. **Clinical Pearls for NEET-PG:** * **Oxygen Effect:** Oxygen is the most potent naturally occurring radiosensitizer. * **Sulfhydryl Compounds:** Most radioprotectors work by scavenging free radicals (produced by indirect action of radiation) or by donating hydrogen atoms to repair DNA lesions. * **Radiosensitizers list:** BUDR, IUDR, Metronidazole, Misonidazole, and Cisplatin. * **Radioprotectors list:** Amifostine, Cysteine, Cysteamine, Vitamin E, and certain cytokines (IL-1, TNF-alpha).
Question 4: What is observed in the part of the bone which received radiotherapy?
- A. Response to radiotherapy is good
- B. Fast healing
- C. More destruction of bone (Correct Answer)
- D. Tumor regression is not affected
Explanation: ***More destruction of bone*** - Radiotherapy causes **radiation osteitis** and **osteoradionecrosis**, leading to progressive bone destruction and necrosis. - **Impaired vascularization** and cellular damage result in weakened bone structure and increased susceptibility to fractures. *Response to radiotherapy is good* - While radiotherapy may effectively treat tumors, the **bone tissue itself responds poorly** to radiation exposure. - **Bone cells** (osteoblasts and osteocytes) are particularly sensitive to radiation damage, leading to compromised bone integrity. *Fast healing* - Radiation actually **impairs bone healing** by damaging blood vessels and reducing cellular regeneration capacity. - **Delayed union** or **non-union** of fractures is common in irradiated bone due to compromised osteoblastic activity. *Tumor regression is not affected* - While tumor regression may occur with adequate radiation doses, this doesn't address the **direct effects on bone tissue**. - The question specifically asks about bone changes, not tumor response to radiotherapy.
Question 5: Which of the following statements about Linear Energy Transfer (LET) is true?
- A. Low LET radiations are more lethal.
- B. It is a property of the tissue.
- C. It is the same as relative biological effectiveness.
- D. High LET radiations have a low oxygen enhancement ratio. (Correct Answer)
Explanation: **Explanation:** **1. Why the Correct Answer is Right:** Linear Energy Transfer (LET) is the rate at which energy is deposited as an ionizing particle travels through matter (keV/µm). **High LET radiations** (e.g., alpha particles, neutrons) cause dense, direct ionization of DNA, leading to irreparable double-strand breaks. Because this damage is direct and physical, it does not rely on the presence of oxygen to "fix" the damage (the Oxygen Fixation Hypothesis). Therefore, High LET radiations have a **low Oxygen Enhancement Ratio (OER)**, meaning they are nearly as effective in hypoxic conditions as they are in oxygenated ones. **2. Why the Incorrect Options are Wrong:** * **Option A:** Low LET radiations (e.g., X-rays, Gamma rays) are **less lethal** per unit dose because they cause sparse ionizations and rely heavily on indirect action (free radical formation), which cells can often repair. * **Option B:** LET is a **property of the radiation** (the projectile), not the tissue. It depends on the charge and velocity of the ionizing particle. * **Option C:** LET and Relative Biological Effectiveness (RBE) are related but **not the same**. RBE is a ratio comparing the biological effect of a test radiation to a standard (250 kVp X-rays). As LET increases, RBE generally increases (up to a point of "overkill" at 100 keV/µm). **3. NEET-PG High-Yield Clinical Pearls:** * **OER Formula:** Dose required under hypoxic conditions / Dose required under aerobic conditions. * **OER Values:** For X-rays (Low LET), OER is ~2.5–3.0. For Alpha particles (High LET), OER is ~1.0. * **The "Overkill" Effect:** RBE peaks at an LET of **100 keV/µm**. Beyond this, energy is wasted because the DNA is already "over-killed," and RBE actually decreases. * **Direct vs. Indirect Action:** High LET = Direct action (dominant); Low LET = Indirect action (dominant, mediated by OH• radicals).
Question 6: Acute radiation hepatic damage is most marked between which time period?
- A. 1-7 days
- B. 7-21 days
- C. 21-40 days
- D. 40-100 days (Correct Answer)
Explanation: **Explanation:** **Radiation-Induced Liver Disease (RILD)**, often referred to as radiation hepatitis, is a subacute clinical syndrome. Unlike the immediate "radiation sickness" seen in the GI tract, the liver's response to radiation is delayed due to the slow turnover rate of hepatocytes and vascular endothelial cells. 1. **Why 40–100 days is correct:** The underlying pathophysiology of acute radiation hepatic damage is **Veno-Occlusive Disease (VOD)**. Following radiotherapy, there is a progressive obstruction of the central veins of the liver lobules due to fibrin deposition and endothelial swelling. This process takes time to manifest clinically. Symptoms typically peak between **2 to 6 weeks (subacute phase)** but the most marked clinical and pathological damage is classically observed between **40 and 100 days** post-exposure. 2. **Why other options are incorrect:** * **1–7 days:** This period corresponds to the *Prodromal phase* of radiation syndrome (nausea, vomiting), not specific organ parenchymal damage. * **7–21 days:** This is the *Latent period* for the liver. While hematopoietic damage (bone marrow) manifests here, the liver remains clinically asymptomatic. * **21–40 days:** This is the early onset period. While damage begins, it has not yet reached its "most marked" or peak clinical presentation. **High-Yield Clinical Pearls for NEET-PG:** * **Pathological Hallmark:** Central venous congestion and "Veno-occlusive disease" (VOD). * **Clinical Triad:** Hepatomegaly, ascites, and elevated alkaline phosphatase (disproportionate to bilirubin). * **Tolerance Dose (TD 5/5):** The whole-liver tolerance dose is approximately **30–35 Gy**. Exceeding this significantly increases the risk of RILD. * **Radiological Sign:** On CT, acute radiation hepatitis appears as a well-defined area of low attenuation corresponding exactly to the radiation portal.
Question 7: Radiation therapy to hypoxic tissues may be potentiated by treatment with which of the following?
- A. Mycostatin
- B. Metronidazole (Correct Answer)
- C. Methotrexate
- D. Melphalan
Explanation: ### Explanation **The Oxygen Effect and Radiosensitizers** The correct answer is **Metronidazole**. In radiobiology, the "Oxygen Effect" states that cells are more sensitive to ionizing radiation in the presence of molecular oxygen. Oxygen acts as a **radiosensitizer** by reacting with free radicals produced by radiation to create permanent, irreparable DNA damage (the Oxygen Fixation Hypothesis). Solid tumors often contain **hypoxic zones** (low oxygen), making them resistant to radiotherapy. To overcome this, chemical **hypoxic cell sensitizers** are used. **Metronidazole** and other nitroimidazoles (like Misonidazole and Nimorazole) act as "oxygen mimics." They possess high electron affinity, allowing them to mimic the sensitizing effect of oxygen in hypoxic tissues, thereby potentiating the effects of radiation. **Analysis of Incorrect Options:** * **A. Mycostatin (Nystatin):** An antifungal medication used for Candida infections; it has no role in modulating radiation sensitivity. * **C. Methotrexate:** A folate antagonist chemotherapy agent. While it is a cell-cycle specific drug, it is not classified as a specific hypoxic cell radiosensitizer. * **D. Melphalan:** An alkylating agent used in treating multiple myeloma. It is a radiomimetic drug (mimics radiation damage) but does not specifically potentiate radiation in hypoxic conditions like nitroimidazoles do. **High-Yield Clinical Pearls for NEET-PG:** * **Oxygen Enhancement Ratio (OER):** The ratio of doses administered under hypoxic vs. aerated conditions to achieve the same biological effect. For X-rays, OER is typically **2.5 to 3.0**. * **Hypoxic Sensitizers:** Look for drugs with the suffix "-nidazole." **Nimorazole** is currently the most clinically utilized agent in this class (specifically for head and neck cancers). * **Hyperbaric Oxygen:** Another method to overcome hypoxia, though less practical than chemical sensitizers.
Question 8: Radiation caries is caused by irradiation of which structure?
- A. Salivary glands (Correct Answer)
- B. Enamel
- C. Enamel and dentin
- D. Oral mucosa
Explanation: **Explanation:** **Radiation caries** is a rampant form of dental decay that occurs as a secondary complication of radiotherapy for head and neck cancers. **Why Salivary Glands is correct:** The primary cause is not the direct effect of radiation on the teeth, but rather the **indirect effect** of irradiation on the **major salivary glands** (especially the parotid). Radiation causes fibrosis and atrophy of the acinar cells, leading to **Xerostomia** (severe dry mouth). Saliva normally acts as a buffer, provides mechanical cleansing, and contains minerals (calcium/phosphate) for remineralization. When salivary flow is reduced, the oral pH drops, and the protective buffering capacity is lost, leading to rapid demineralization and "radiation caries." **Why other options are incorrect:** * **Enamel & Dentin:** While high doses of radiation can theoretically alter the organic matrix of teeth, mature enamel and dentin are highly radioresistant. The decay seen in these patients is primarily due to the altered oral environment (lack of saliva) rather than direct structural damage to the tooth. * **Oral Mucosa:** Irradiation of the mucosa leads to **mucositis**, which causes pain and ulceration. While this may make oral hygiene difficult, it is not the physiological cause of the caries itself. **High-Yield Clinical Pearls for NEET-PG:** * **Characteristic Appearance:** Radiation caries typically starts at the **cervical (neck) region** of the teeth and can lead to the amputation of the crown. * **Threshold:** Salivary glands are highly radiosensitive; permanent xerostomia can occur at doses as low as **20-30 Gy**. * **Prevention:** Patients should undergo dental evaluation *before* starting radiotherapy and use topical fluoride applications during/after treatment. * **Osteoradionecrosis (ORN):** Another complication of radiation, usually affecting the **mandible** due to its decreased vascularity compared to the maxilla.
Question 9: What is the most important lesion produced in chromosomal DNA by exposure to ionizing radiation?
- A. A break on one DNA strand (single-strand break)
- B. Well-separated breaks on both DNA strands
- C. Breaks on both DNA strands which are opposite each other or separated by only a few bases (double-strand break) (Correct Answer)
- D. Multiple breaks on the same DNA strand
Explanation: **Explanation:** The biological effects of ionizing radiation are primarily mediated through damage to the DNA molecule. While radiation can cause various types of lesions, the **Double-Strand Break (DSB)** is considered the most significant and lethal lesion. **1. Why Option C is Correct:** A Double-Strand Break occurs when both sugar-phosphate backbones are severed at locations directly opposite each other or separated by only a few base pairs. Unlike single-strand breaks, DSBs are difficult for the cell to repair accurately. If repaired incorrectly (misrepair), it leads to chromosomal aberrations, mutations, or carcinogenesis. If unrepaired, it leads to **mitotic death** (the most common form of cell death following radiation). Therefore, DSBs are the primary cause of radiation-induced cell killing and genetic damage. **2. Why Other Options are Incorrect:** * **Option A & D:** Single-strand breaks (SSBs) and multiple breaks on the same strand are very common but are usually repaired with high fidelity using the opposite intact strand as a template (via Base Excision Repair). They rarely result in cell death or long-term mutation. * **Option B:** If breaks on opposite strands are well-separated, they are functionally treated as two independent single-strand breaks and are easily repaired. **High-Yield Clinical Pearls for NEET-PG:** * **Direct Action:** Radiation interacts directly with DNA (common with high-LET radiation like alpha particles). * **Indirect Action:** Radiation interacts with water to form **Free Radicals** (e.g., OH•), which then damage DNA (common with low-LET radiation like X-rays/Gamma rays). * **Radiosensitivity:** Cells are most sensitive in the **M phase** and late **G2 phase** of the cell cycle; they are most resistant in the late **S phase**. * **Law of Bergonie and Tribondeau:** Stem cells and highly proliferative cells (e.g., bone marrow, intestinal epithelium) are the most radiosensitive.
Question 10: Amifostine is a:
- A. Radiosensitizer
- B. Radioprotector (Correct Answer)
- C. Radio modifier
- D. Radiomimetic
Explanation: **Explanation:** **Amifostine** is a prodrug that is converted by alkaline phosphatase into an active thiol compound (WR-2721). It acts as a **Radioprotector** by scavenging free radicals (specifically hydroxyl radicals) generated by ionizing radiation and by donating hydrogen atoms to repair damaged DNA. Its clinical utility stems from **differential protection**: normal tissues have higher alkaline phosphatase activity and better vascularity than tumor cells, allowing Amifostine to accumulate preferentially in healthy tissue. This protects normal organs (like salivary glands) from radiation-induced damage without protecting the tumor. **Analysis of Options:** * **A. Radiosensitizer:** These are agents (e.g., Oxygen, Misonidazole, Cisplatin) that make tumor cells *more* sensitive to radiation. Amifostine does the opposite by protecting cells. * **C. Radio modifier:** This is a broad umbrella term that includes both sensitizers and protectors. While technically true, "Radioprotector" is the specific and most accurate classification. * **D. Radiomimetic:** These are drugs (e.g., Nitrogen mustard, Cyclophosphamide) that mimic the effects of ionizing radiation by causing similar DNA damage. **High-Yield Clinical Pearls for NEET-PG:** * **FDA Approval:** Amifostine is specifically used to reduce the incidence of **xerostomia** (dry mouth) in patients undergoing radiotherapy for head and neck cancers. * **Side Effects:** The most common dose-limiting side effect is **hypotension**; others include nausea, vomiting, and hypocalcemia. * **Time of Administration:** It must be administered intravenously shortly before radiation therapy to be effective.
Practice by Chapter
Cellular Effects of Radiation
Practice Questions
Radiation-Induced DNA Damage
Practice Questions
Cell Survival Curves
Practice Questions
Radiation Effects on Normal Tissues
Practice Questions
Acute Radiation Syndrome
Practice Questions
Late Effects of Radiation
Practice Questions
Radiotherapeutic Ratio
Practice Questions
Fractionation in Radiotherapy
Practice Questions
Oxygen Effect and Radiosensitizers
Practice Questions
Radiation Carcinogenesis
Practice Questions
Radiation in Pregnancy
Practice Questions
Biological Dosimetry
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free